Southport Reporter (R) Bourder
Southport & Mersey Reporter - Mobile

Click on here to go to latest edition's main page.

  Search Edition Archive  

Visit our online shop...


Click on to go to our hub website.

Latest Edition   Archive   Shop   Email   Mersey Reporter
Please support our advertiser below...

For more recommended businesses click on here...

Weekly Edition - Published  18 April 2016


Local News Report - Mobile Page


Cutting edge service available to Liverpool prostate cancer patients

PATIENTS at the Royal Liverpool and Broadgreen University Hospitals will be the 1st outside London to receive cutting edge prostate cancer diagnostic services. 

The Trust is the 1st and only site in the country outside of London to provide the ground breaking new Prostate Specific Membrane Antigen (PSMA) test using their PET/CT (positron emission tomography computed tomography) scanner.

Nuclear medicine specialists from the Royal Liverpool and Broadgreen Hospitals NHS Trust are working with the highly specialised radiopharmacy staff as well as consultants from Urology, Oncology and Radiology.

The test is based on a completely new method for spotting the early signs of a returning prostate cancer.  It aims to increase life expectancy for patients with a variety of long term conditions including cancer and heart disease and to address the complex health needs of some groups of patients.  Radioactive material is injected into a vein and can be viewed on the PET/CT scanner. The scans can potentially identify cancer cells that have spread beyond the prostate gland.  A team of specialists can then identify a treatment plan, which specifically targets and treats the patient's specific type of cancer.  This also means that if treatment is required it can begin sooner, and for those patients that do not require treatment they can be reassured.

Mr Cornford, consultant urological surgeon at the Royal Liverpool University Hospital said:- "We want to deliver the best treatment to our patients, revolutionary diagnostic tests greatly impacts on a patient's diagnosis. Understanding the benefits of this new test is pivotal in the fight against prostate cancer. PMSA/PET scanning will help us to identify prostate cancer recurrence earlier. This will allow us to provide innovative treatments which are personalised to patient's diagnosis. The continuous work will create the opportunity to research into developing cures."

Professor Vinjamuri, lead consultant in nuclear medicine at the Royal Liverpool University Hospital added:- "The launch of this test in Liverpool ahead of other bigger cancer centres has been made possible because of our unique and specialist expertise in the fields of radiopharmacy, nuclear medicine and medical imaging. The PSMA test is part of a programme of continuous research and development into diagnostic tests which brings us another step closer to providing the best care possible to our patients"

The collaboration and investment of clinical expertise and time to develop the research is vital in helping to continue delivering the best care to cancer patients across Merseyside and surrounding areas.


News Report Page Quick Flick.

Click on here to go to the mobile menu page for this edition. News Report Page Quick Flick

Read this page.

Southport Reporter (R) Bourder




 RSS Our Weekly Headlines


(+44)  08443 244 195
Calls to this number may be recorded for security, broadcast, training and record keeping.

4a Post Office Ave, Southport, Merseyside, PR9 0US, UK


Click on to see our Twitter Feed.  Click on to see our Facebook Page.  Click on to follow our LinkedIn Profile. This website is licence to carry news from and UK Press Photography. 

This is our media complains system...

We are regulated by IMPRESS, the independent monitor for the UK's press.

How to make a complaint
Complaints Policy
Complaints Procedure
Whistle Blowing Policy


Southport Reporter® is the
Registered Trade Mark of Patrick Trollope